The Annals of Internal Medicine analysis of 5,619 NHANES participants (observational, cross-sectional design, no reported conflicts) reveals that 26% of adults with normal BMI and 50% classified as overweight actually meet obesity criteria via waist-to-hip ratio (WHR), highlighting how BMI conflates lean mass with visceral fat. This underestimation is not merely technical; it propagates through CDC and WHO guidelines that anchor insurance coverage, pharmacologic eligibility, and surgical thresholds to BMI thresholds, leaving metabolically compromised patients without intervention. A 2023 pooled analysis in JAMA Network Open (n>300,000, prospective cohorts) found WHR exhibited the strongest dose-response relationship with all-cause mortality across BMI strata, independent of total adiposity. Complementary evidence from the 2022 INTERHEART case-control study (observational, n=27,000) linked elevated WHR to myocardial infarction risk more tightly than BMI, underscoring fat distribution as the operative pathway rather than weight alone. Clinical inertia persists because BMI requires no equipment, yet this convenience systematically masks central adiposity in muscular or sarcopenic individuals, delaying lifestyle or GLP-1 interventions until overt disease emerges. Public health messaging built on BMI therefore understates population-level risk, particularly among non-White groups where visceral fat accumulates at lower BMIs.